Institute of Circulatory and Respiratory Health (ICRH)
Institute of Aboriginal Peoples' Health (IAPH)
Institute of Gender and Health (IGH)
Institute of Human Development, Child and Youth Health (IHDCYH)
Institute of Infection and Immunity (III)
Institute of Population and Public Health (IPPH)
In partnership with
The Ministry of Health of Mexico (MOH)
The Mexican Institute for Social Security (IMSS)
The Institute for Social Security and Services for Federal Employees (ISSSTE)
The National Council for Science and Technology (CONACyT)
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | October 18, 2006 (Important Dates) |
| October 27, 2006 | Full applications must be courier stamped by this date. (Updated: 2006-10-18) |
| November 15 2006 | Anticipated notification of decision. |
| November 30, 2006 | Anticipated start date. |
| Funds Available | |
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
| |
| Summary | |
| The Program, established in 2004, is jointly managed and funded by the Fondo Sectorial de Investigacion Salud y Seguridad Social (Health and Social Security Sectorial Research Fund) (FOSISS) and the Canadian Institutes of Health Research (CIHR). Its aim is to promote the development of Mexican-Canadian scientific co-operation between universities or affiliated research organizations in Mexico and Canada through the support of collaborative research project grants. The Health and Social Security Sectorial Fund (FOSISS) is a trust formed between CONACyT and the Health Sector Institutions in Mexico in order to administer research funds in health and for technological development in the area, and to be performed by Mexican researchers and institutions | |
Background
Partners
Objectives
Eligibility
Allowable Costs
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
Communications Requirements
Monitoring, Performance Measurement and Evaluation
How to Apply
Contact Information
Description of Partners
The aim of this program is to promote the development of scientific co-operation between universities or affiliated research organizations in Mexico and Canada through the support of collaborative research project grants.
Tuberculosis (TB) is an important issue in Global Health, and was declared a Global Health Emergency by the WHO in 1993. Both countries wish to collaborate in order to develop better strategies on the operational issues on TB program management as a way to improve health in such communities and render health access and services more equitable.
The Program promotes excellent multi-disciplinary, multi-institutional, multi-sectoral research on TB in Mexico and Canada, through collaborative research programs.
The Institute of Circulatory and Respiratory Health is dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding for this strategic initiative, and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of this particular initiative. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join in this initiative. The specific research foci and requirements for each partner are outlined in the section "Objectives".
The specific objectives of this initiative are to promote collaboration between Canadian and Mexican researchers in the area of Tuberculosis in regards to health research, research training, and knowledge translation and to help develop sustainable networks of researchers in this area.
Relevant Research Areas:
Applications in all areas of tuberculosis research across the four themes of CIHR are encouraged and examples include the following research areas:
It is envisaged that the collaborative research program will include but is not limited to one of the following:
The CIHR Institutes and FOSISS will provide funding for applications that are relevant to (in alignment with) the objectives and research priority areas described above.
Prior to peer review, the CIHR Institutes and FOSISS will have access to anonymized project titles and summaries to conduct relevance review. Applications that are deemed relevant will be forwarded to peer review.
The following criteria will be used in conducting the relevance review.
The review of applications for relevance to the strategic initiative will have no impact on the peer review process.
Eligibility criteria for all CIHR research funding programs apply to the Canadian team members. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Mexican applicants must adhere to eligibility criteria of FOSISS.
Randomized Controlled Trials will NOT be considered under this RFA.
Specific Eligibility Requirements
Eligibility requirements specific to this Request for Applications include the following:
Applicants should review the Tri-Agency (CIHR, NSERC and SSHRC) financial administration guidelines Use of Grant Funds for a complete listing and description of allowable costs and activities.
The full application must provide a detailed justification of all costs. Allowable costs incurred in the projects may include:
A peer review committee established by CIHR and FOSISS will evaluate the full applications. The committee will be created specifically for this Request for Applications. Committee members are selected based on suggestions from many sources including FOSISS, the institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.
Peer review will be conducted in accordance with The CIHR Peer Review Process: Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors for Assessment" (section 6.2).
In addition, the following evaluation criteria specific to this Request for Applications will apply. CIHR recognizes that applications will emphasize different approaches to research and to knowledge translation, therefore reviewers and committees are expected to weight criteria such as these differently from one application to another.
Upon completion of peer review, CIHR and FOSISS will receive the ranking list, merit scores (ratings) and recommendations of the peer review committee with regards to funding level and award term, for the submitted applications that fall in the fundable range and have been determined to be relevant to the specific research areas and objectives of the initiative. The list will be used for funding decision-making purposes and will remain anonymous.
This Request for Applications will follow the General Guidelines for Grant Programs. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
Mexican principal applicants should also consult the General Guidelines established by FOSISS.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document. FOSISS and CIHR will jointly approve the projects to be funded.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
Grant recipients are required to acknowledge CIHR, its institutes and FOSISS in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes / FOSISS will be identified on the Authorization for Funding and decision letter.
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
Applicants are required to submit a progress report after the first year and at the end of the two year grant to FOSISS and CIHR. The report should summarize the results and describe how the grant funds were used.
Review the application instructions provided in How to Apply for Funding.
Select "Operating Grants" (Registration and Application) from the Grant Programs Application Packages.
The Canadian co-principal applicant must submit the original and 6 copies of the Canadian-Mexican joint application to CIHR by September 15th, 2006. The full application should include the following:
1. Research Module
* Signature page, Page 2a (Please insert the Mexican researcher as a Principal Applicant by obtaining a CIHR PIN.
*Applicants are advised to follow the instructions on the Acceptable Application Module Formats page which outlines formatting requirements for attachments.
2. Operating Budget Module (including the costs of personnel, travel, supply/ equipment, specific details about personnel, etc.), which fully justifies each item of funding requested. Please delineate the budget breakdown between Canadian and Mexican costs. The breakdown of funds provided to the Mexican Principal Applicant should be listed in the column "Other Funding Sources" of the Operating Budget Module.
3. Common CV (must be completed for Canadian and Mexican Principal Applicants only).
Send the completed registration and application packages by courier to:
RE: "Mexico-Canada Joint Health Research Program in Tuberculosis"
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
The Mexican co-principal applicant must complete and submit the Canadian-Mexican joint application form on-line by September 15th, 2006. All requested data and information must be completed.
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Grace Almasi
Program Delivery Coodinator
Canadian Institutes of Health Research
Telephone: (613) 941-3420
Fax: (613) 954-1800
Email: galmasi@cihr-irsc.gc.ca
For questions about this initiative and research objectives contact:
Elissa Hines Reimer
Assistant Director, Institute of Circulatory and Respiratory Health
Canadian Institutes of Health Research
160 Elgin Street, 9th Floor
Address Locator 4809A
Ottawa ON K1A 0W9
Canada
Telephone: (613) 954-0544
Email: ehinesreimer@cihr-irsc.gc.ca
INS/FOSISS Representative
Dr. Francisco Becerra
Mexico-Canada Joint Health Research Program in Tuberculosis
Periferico Sur 4118-1
Edificio Zafiro 1
Jardines del Pedregal
Mexico DF 01900
Telephone: (5255) 5135 0551
Email: fbecerra@salud.gob.mx
Note: Additional partners, including partners from industry and the private sector are expected to join this funding initiative over the coming year.
Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
CIHR - Institute of Circulatory and Respiratory Health (ICRH)
Supports research into causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, [critical care] and [sleep].
CIHR - Institute of Aboriginal Peoples' Health (IAPH)
The Canadian Institutes of Health Research - Institute of Aboriginal Peoples' Health supports health research that addresses the special health needs of Aboriginal peoples in Canada, and aims to improve the health of First Nations, Inuit and Métis peoples through the assertion of indigenous understandings of health and by fostering innovative community-based and scientifically excellent research.
IAPH will support research collaborations in TB that focus on Aboriginal/Indigenous peoples and include evidence of support from indigenous community leaders.
CIHR - Institute of Gender and Health (IGH)
The mandate of the CIHR Institute of Gender and Health (IGH) supports research that addresses how sex (biological-genetic factors) and gender (social-cultural experiences) interact with other socio-cultural, bio-physical, and political-economic factors to influence health, and create conditions that differ with respect to risk factors or effective interventions for males and females throughout the lifespan. Five research priorities were identified following extensive national consultations: (1) access and equity for vulnerable populations; (2) promoting health in the context of chronic and infectious conditions and disabilities; (3) gender and health across the lifespan; (4) promoting positive health behaviours and preventing addictions; and (5) gender and physical and social environments.
The Institute of Gender and Health strongly encourages applicants to demonstrate the use of sex/gender-based or sex/gender-sensitive analysis (SGBA) in applications. SGBA is an approach to research and evaluation which systematically inquires about biological (sex-based) and sociocultural (gender-based) differences between women and men, boys and girls, without presuming that any such differences exist. The purpose of SGBA is to promote rigorous sex/gender-sensitive health research which expands understanding of health determination in both sexes, in order to provide knowledge which can result in improvements in health and health care. IGH is currently examining various ways to stimulate substantive SGBA practice among the research community. In the meantime, we refer you to the Canadian resource on SGBA policy and practice published by Health Canada.
* Please note that if you locate and/or use alternate sex and gender sensitive guidelines, IGH would appreciate their citation.
CIHR - Institute of Human Development, Child and Youth Health (IHDCYH)
Supports research to enhance maternal, child, and youth health and to address causes, prevention, screening, diagnosis, treatment, short- and long-term support systems, and palliation for a wide range of health concerns associated with reproduction, early development, childhood, and adolescence.
CIHR - Institute of Infection and Immunity (III)
Seeks to establish national leadership, priorities and programs that promote innovative research to reduce the global burden of infection and immune-based disease and improve quality of life.
CIHR - Institute of Population and Public Health (IPPH)
Supports research into the complex interactions, which determine health, and its application to improve the health of individuals, communities and global populations.
Partners
The Ministry of Health of Mexico
The Mexican Institute for Social Security (IMSS)
The Institute for Social Security and Services for Federal Employees (ISSSTE)
The National Council for Science and Technology (CONACyT)
